Stay updated with breaking news from Thomas Ybert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veteran Life Science Executive and New Board Members Bring Deep Expertise to Advance the Company's Enzymatic DNA Synthesis (EDS) Technology and Commercialize its SYNTAX Platform DNA Script, a leader
DNA Script Advances Evaluation Program for the SYNTAX System, the First Benchtop DNA Printer Powered By Enzymatic Synthesis USA - English Share this article Share this article The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in enabling enzymatic DNA synthesis on demand, today announced the third and final phase of its evaluation program for the SYNTAX System, the world's first benchtop printer powered by Enzymatic DNA Synthesis (EDS) technolog...
DNA Script will receive up to $9.35 million to leverage the company's novel enzymatic DNA synthesis (EDS) technology for the project This is the second announced project[1] where DNA Script
DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand PARIS and SOUTH SAN FRANCISCO, Calif., February 23, 2021 DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH announced today an exclusive licensing agreement that grants DNA Script use of the novel "Click" chemistry commercialized by baseclick. In effect, this agreement enables DNA Script's customers to enzymatically synthesize high purity nucleic acids with modifications using their SYNTAX™ DNA printing system. Click chemistry was originall...
Company will receive $1.6 Million to develop a qPCR probe manufacturing platform to enable the fast detection of highly pathogenic viruses and bacteria DNA Script, a leading pioneer in enabling DNA